Purdue Pharma’s Creditors Overwhelmingly Endorse Bankruptcy Plan
If approved by a judge next month, the plan would [...]
Vaccine Makers Are Asked to Expand Safety Studies on Children
The F.D.A. wants Pfizer and Moderna to increase the number [...]
Johnson & Johnson podría ser menos eficaz contra la variante delta
Muchos de los que recibieron la vacuna pueden necesitar refuerzos, [...]
Headache Research Advances Though Cures Are Elusive
Research into these often mysterious and debilitating disorders has languished. [...]
Biogen’s Aduhelm Sales Total $2 Million in Second Quarter
The drug from Biogen, called Aduhelm, is expected to generate [...]
J.&J. Vaccine May Be Less Effective Against Delta, Study Suggests
Many who received the shot may need to consider boosters, [...]
States and Cities Near Tentative $26 Billion Deal in Opioids Cases
The agreement would end thousands of lawsuits against the three [...]
How an Unproven Alzheimer’s Drug Got Approved
Though some of its own senior officials said there was [...]
Ohio Clinic Says It Won’t Administer Alzheimer’s Drug to Patients
The rejection of the new Alzheimer’s drug by the two [...]
Johnson & Johnson Recalls Sunscreen Because of Benzene Traces
The company said it had determined that daily exposure to [...]